156 related articles for article (PubMed ID: 6254642)
1. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
Kataoka T; Oh-hashi F; Sakurai Y; Gomi K
Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
[TBL] [Abstract][Full Text] [Related]
2. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
Kataoka T; Ogihara K; Sakurai Y
Cancer Res; 1980 Oct; 40(10):3839-45. PubMed ID: 6449286
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432.
Kataoka T; Oh-hashi F; Sakurai Y
Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
Kataoka T; Yamamoto T; Honjo K; Murayama T
Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
[TBL] [Abstract][Full Text] [Related]
5. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
Kataoka T; Oh-hashi F
Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
[TBL] [Abstract][Full Text] [Related]
6. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity.
Kataoka T; Oh-hashi F; Sakurai Y
Gan; 1979 Apr; 70(2):155-64. PubMed ID: 111995
[TBL] [Abstract][Full Text] [Related]
7. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
Kataoka T; Akahori Y; Sakurai Y
Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole.
Kataoka T; Tsukagoshi S; Sakurai Y; Okabe M
Gan; 1979 Aug; 70(4):515-9. PubMed ID: 510850
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
Ujiie T
Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
[TBL] [Abstract][Full Text] [Related]
10. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
Gerlier D; Avice T; Doré JF
Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733
[TBL] [Abstract][Full Text] [Related]
12. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica.
Lotzova E; Gallagher MT; Trentin JJ
Biomedicine; 1975 Sep; 22(5):387-92. PubMed ID: 177111
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
Kataoka T; Oh-Hashi F; Sakurai Y
Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
Miura T; Maekawa T; Kurashige S; Mitsuhashi S
Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
[TBL] [Abstract][Full Text] [Related]
15. Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine.
Kataoka T; Oh-hashi F
Cancer Res; 1985 May; 45(5):2139-44. PubMed ID: 3157443
[TBL] [Abstract][Full Text] [Related]
16. Promotion of tumor growth in vivo by antimacrophage agents.
Keller R
J Natl Cancer Inst; 1976 Dec; 57(6):1355-61. PubMed ID: 187804
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
Marcelletti J; Furmanski P
J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
[TBL] [Abstract][Full Text] [Related]
18. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Rao VS; Mitchell MS
J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
[TBL] [Abstract][Full Text] [Related]
19. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
Mitchell MS; Mokyr MB; Goldwater DJ
Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
[TBL] [Abstract][Full Text] [Related]
20. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
